Lexology March 7, 2024
Zhong Lun Law Firm

Recently, cross-border data transfer regulatory policies in both the US and China have shown divergent trends. The Chinese government has adopted a policy orientation that is strict yet increasingly accommodating, actively responding to the demands of foreign enterprises and exploring a dual model of “post-approval flow + free flow.” On the other hand, in the US, President Biden signed the Executive Order on Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern on February 28. The US Department of Justice issued a fact sheet on proposed rulemaking associated with this Executive Order on the same day. Future transactions involving a significant volume of human genomic data, personal health data, and other sensitive...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Congress / White House, Govt Agencies, Healthcare System, Privacy / Security
Related Articles:
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
PBM reform dropped in Congress' funding package
Trump's Picks for Top Health Jobs Not Just Team of Rivals but 'Team of Opponents'
Telehealth gets short extension, physician pay is cut in spending bill
From Book Burnings to Data Deletions: Safeguarding Health Info in the Digital Age

Share This Article